Bluejay Diagnostics (BJDX) Non Operating Income (2020 - 2026)
Bluejay Diagnostics recorded quarterly Non Operating Income of $731.0 in Q1 2026, down 97.71% quarter-over-quarter from $31935.0 in Q4 2025, and down 89.06% year-over-year from $6681.0 in Q1 2025.
Bluejay Diagnostics' Non Operating Income history runs 7 years deep, the most recent figure standing at $731.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 89.06% year-over-year to $731.0; the TTM figure through Mar 2026 stood at $51706.0 (down 92.01% YoY), while the FY2025 annual figure was $104489.0, down 19.02% from the prior year.
- Non Operating Income came in at $731.0 for Q1 2026 at Bluejay Diagnostics, down from $31935.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $729859.0 in Q4 2024 to a low of -$149711.0 in Q3 2022.
- A 5-year average of $77898.3 and a median of $43235.0 in 2023 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 769.07% in 2024 and fell as far as 378.37% in 2024.
- Bluejay Diagnostics' Non Operating Income stood at $214994.0 in 2022, then sank by 60.94% to $83982.0 in 2023, then soared by 769.07% to $729859.0 in 2024, then sank by 95.62% to $31935.0 in 2025, then slumped by 97.71% to $731.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $731.0, $31935.0, and $19315.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.80 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 731.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 731.00 |
| Dec 31, 2025 | 31,935.00 |
| Sep 30, 2025 | 19,315.00 |
| Jun 30, 2025 | -275.00 |
| Mar 31, 2025 | 6,681.00 |
| Dec 31, 2024 | 729,859.00 |
| Sep 30, 2024 | -120,352.00 |
| Jun 30, 2024 | 30,944.00 |
| Mar 31, 2024 | 99,640.00 |
| Dec 31, 2023 | 83,982.00 |
| Sep 30, 2023 | 43,235.00 |
| Jun 30, 2023 | 90,383.00 |
| Mar 31, 2023 | 139,729.00 |
| Dec 31, 2022 | 214,994.00 |
| Sep 30, 2022 | -149,711.00 |
| Jun 30, 2022 | 48,323.00 |
| Mar 31, 2022 | 54,858.00 |
| Dec 31, 2021 | -87,591.00 |
| Sep 30, 2021 | -235,393.00 |
| Jun 30, 2021 | 25,839.00 |
| Mar 31, 2021 | 39,010.00 |
| Dec 31, 2020 | 37,754.00 |
| Sep 30, 2020 | 20,181.00 |